Please login to the form below

Not currently logged in
Email:
Password:

Tyvyt

This page shows the latest Tyvyt news and features for those working in and with pharma, biotech and healthcare.

Eli Lilly, Innovent showcase Tyvyt data in first-line NSCLC

Eli Lilly, Innovent showcase Tyvyt data in first-line NSCLC

Although median overall survival (OS) was not reached in both groups, OS showed an improvement favouring the Tyvyt combination. ... Tyvyt’s major rival is Merck &Co’s Keytruda (pembrolizumab), which holds approvals across a range of NSCLC indications.

Latest news

  • China updates drug reimbursement list, agrees price cuts China updates drug reimbursement list, agrees price cuts

    Also included on the updated list is the PD-1 inhibitor Tyvyt (sintilimab) – jointly developed by Innovent Biologics and Eli Lilly – for the treatment of relapsed/refractory Hodgkin’s lymphoma. ... If approved, it could directly rival

  • Innovent gears up for PD-1 inhibitor launch in China Innovent gears up for PD-1 inhibitor launch in China

    Chinese biotech Innovent is in the final stages of preparing to launch its cancer immunotherapy Tyvyt in its home market. ... The approval of Tyvyt…enables Innovent's delivery on its social responsibility to offer innovative drugs affordable to

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics